Humacyte, Inc. (HUMA) Tops Q4 EPS by 9c

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Microsoft plans data center push to triple its computing power - Bloomberg
• Laser Photonics prices $7.9M public offering at $0.75 per share
• Wedbush Assumes Tenable (TENB) at Underperform